Kathryn Daveson

896 total citations
15 papers, 302 citations indexed

About

Kathryn Daveson is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Epidemiology. According to data from OpenAlex, Kathryn Daveson has authored 15 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Applied Microbiology and Biotechnology and 6 papers in Epidemiology. Recurrent topics in Kathryn Daveson's work include Antibiotic Use and Resistance (7 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Kathryn Daveson is often cited by papers focused on Antibiotic Use and Resistance (7 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Kathryn Daveson collaborates with scholars based in Australia, United Kingdom and Uganda. Kathryn Daveson's co-authors include Marion L. Woods, Chris Del Mar, Deborah Marriott, Jan‐Willem C. Alffenaar, Jason A. Roberts, Karina Kennedy, Lorraine Anderson, Steven Y. C. Tong, Asha C Bowen and Sebastiaan J. van Hal and has published in prestigious journals such as British Journal of Clinical Pharmacology, The Medical Journal of Australia and Infection Control and Hospital Epidemiology.

In The Last Decade

Kathryn Daveson

14 papers receiving 298 citations

Peers

Countries citing papers authored by Kathryn Daveson

Since Specialization

Citations

This map shows the geographic impact of Kathryn Daveson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Daveson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Daveson more than expected).

Fields of papers citing papers by Kathryn Daveson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Daveson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Daveson. The network helps show where Kathryn Daveson may publish in the future.

Co-authorship network of co-authors of Kathryn Daveson

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Daveson. A scholar is included among the top collaborators of Kathryn Daveson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Daveson. Kathryn Daveson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Implementation of a novel antimicrobial stewardship strategy for rural facilities utilising telehealth 2021 ·International Journal of Antimicrobial Agents ·Minyon Avent, (unknown), (unknown), Eva Malacova, Courtney Brown, (unknown), S. Ashley, Kathryn Daveson	10
2	Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021 2021 ·Internal Medicine Journal ·(unknown), Kathryn Daveson, Jan‐Willem C. Alffenaar, Amanda Gwee, (unknown), Deborah Marriott, Jason A. Trubiano, (unknown), Jason A. Roberts	46
3	Emerging therapeutic drug monitoring of anti‐infective agents in Australian hospitals: Availability, performance and barriers to implementation 2021 ·British Journal of Clinical Pharmacology ·Indy Sandaradura, Jan‐Willem C. Alffenaar, Menino Osbert Cotta, Kathryn Daveson, Richard O. Day, Sebastiaan J. van Hal, (unknown), Deborah Marriott, Jonathan Penm, Jason A. Roberts, Alexis Tabah, (unknown), Sahand Imani	28
4	Antimicrobial stewardship in remote primary healthcare across northern Australia 2020 ·PeerJ ·(unknown), Lorraine Anderson, Asha C Bowen, Kirsty Buising, Christine Connors, Kathryn Daveson, (unknown), (unknown), (unknown), Rodney James, (unknown), (unknown), (unknown), Steven Y. C. Tong, Jodie McVernon	19
5	Therapeutic drug monitoring of commonly used anti-infective agents: A nationwide cross-sectional survey of Australian hospital practices 2020 ·International Journal of Antimicrobial Agents ·Sahand Imani, Jan‐Willem C. Alffenaar, Menino Osbert Cotta, Kathryn Daveson, Sebastiaan J. van Hal, (unknown), Debbie Marriott, Jonathan Penm, Jason A. Roberts, Alexis Tabah, (unknown), (unknown), Indy Sandaradura	22
6	Risk factors for candidaemia: A prospective multi‐centre case‐control study 2020 ·Mycoses ·Caitlin Keighley, A. L. Pope, Deborah Marriott, Belinda Chapman, Narin Bak, Kathryn Daveson, Krispin Hajkowicz, Catriona Halliday, Karina Kennedy, Sarah Kidd, Tania C. Sorrell, (unknown), Sebastiaan J. van Hal, Monica A. Slavin, Sharon C.‐A. Chen	27
7	Optimal antimicrobial duration for common bacterial infections 2019 ·Australian Prescriber ·(unknown), Kathryn Daveson, Chris Del Mar	34
8	Vancomycin-resistant Enterococcus (VRE) outbreak in a neonatal intensive care unit and special care nursery at a tertiary-care hospital in Australia—A retrospective case-control study 2019 ·Infection Control and Hospital Epidemiology ·Patiyan Andersson, Wendy Beckingham, Claire L. Gorrie, Karina Kennedy, Kathryn Daveson, Susan A. Ballard, Ming Chen, (unknown), (unknown)	16
9	An urgent need for antimicrobial stewardship in Indigenous rural and remote primary health care 2019 ·The Medical Journal of Australia ·Asha C Bowen, Kathryn Daveson, Lorraine Anderson, Steven Y. C. Tong	21
10	Chlorhexidine washing in intensive care does not reduce bloodstream infections, blood culture contamination and drug-resistant microorganism acquisition: an interrupted time series analysis 2018 ·Critical Care and Resuscitation ·(unknown), (unknown), Kathryn Daveson, (unknown), Helen Rodgers, Wendy Beckingham, Karina Kennedy, (unknown), Frank van Haren	9
11	Under the radar: Two prolonged outbreaks of carbapenemase-producing Enterobacteriaceae (CPE) at a tertiary hospital in Canberra, Australia 2017 ·Infection Disease & Health ·(unknown), Kathryn Daveson, David Harley, Karina Kennedy	0
12	Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations 2016 ·International Journal of Antimicrobial Agents ·Catriona Halliday, Sharon C.‐A. Chen, Sarah Kidd, Sebastian van Hal, Belinda Chapman, Christopher H. Heath, (unknown), Karina Kennedy, Kathryn Daveson, Tania C. Sorrell, C. Orla Morrissey, Deborah Marriott, Monica A. Slavin	28
13	Clinical impact of reducing routine blood culture incubation time from 7 to 5 days 2014 ·Pathology ·(unknown), Kathryn Daveson, Karina Kennedy	3
14	BK virus‐associated progressive multifocal leukoencephalopathy 2013 ·The Medical Journal of Australia ·Kathryn Daveson, (unknown), Scott Bowden, Mark E. Koina, Lavinia Hallam	13
15	Lodderomyces elongisporus endocarditis in an intravenous drug user: a new entity in fungal endocarditis 2012 ·Journal of Medical Microbiology ·Kathryn Daveson, Marion L. Woods	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact